Search results for "complex disease"

showing 10 items of 18 documents

Role of curcumin in idiopathic pulmonary arterial hypertension treatment: A new therapeutic possibility

2013

The idiopathic pulmonary arterial hypertension is a complex disease that mainly affects pulmonary arterial circulation. This undergoes a remodeling with subsequent reduction of flow in the small pulmonary arteries. Because of this damage an increased vascular resistance gradually develops, and over time it carries out in heart failure. The inflammatory process is a key element in this condition, mediated by various cytokines. The inflammatory signal induces activation of NF-κB, and prompts TGF-β-related signaling pathway. Clinical evolution leads to progressive debilitation, greatly affecting the patient quality of life. The actual therapeutic approaches, are few and expensive, and include …

CurcuminSettore MED/06 - Oncologia MedicaHypertension PulmonaryComplex diseaseInflammationPharmacologyModels Biologicalchemistry.chemical_compoundTransforming Growth Factor betamedicineidiopathic pulmonary arterial hypertensionHumansFamilial Primary Pulmonary HypertensionCurcumin; idiopathic pulmonary arterial hypertensionbusiness.industryIdiopathic Pulmonary Arterial HypertensionNF-kappa BPhosphodiesteraseGeneral Medicinemedicine.diseaseSettore MED/11 - Malattie Dell'Apparato CardiovascolareIncreased vascular resistancechemistryHeart failureCurcuminVascular Resistancemedicine.symptomSignal transductionbusinessSignal Transduction
researchProduct

Visualizing cell death in experimental focal cerebral ischemia: promises, problems, and perspectives

2011

One of the hallmarks of stroke pathophysiology is the widespread death of many different types of brain cells. As our understanding of the complex disease that is stroke has grown, it is now generally accepted that various different mechanisms can result in cell damage and eventual death. A plethora of techniques is available to identify various pathological features of cell death in stroke; each has its own drawbacks and pitfalls, and most are unable to distinguish between different types of cell death, which partially explains the widespread misuse of many terms. The purpose of this review is to summarize the standard histopathological and immunohistochemical techniques used to identify …

Noninvasive imagingProgrammed cell deathIschemiaComplex diseaseContext (language use)Review ArticleBrain IschemiaBrain ischemia03 medical and health sciences0302 clinical medicineNeuroimagingmedicineAnimalsHumansStroke030304 developmental biology0303 health sciencesMicroscopyCell Deathbusiness.industryBrainmedicine.diseaseImmunohistochemistryMagnetic Resonance ImagingStrokeNeurologyNeurology (clinical)Cardiology and Cardiovascular MedicinebusinessNeuroscience030217 neurology & neurosurgeryJournal of Cerebral Blood Flow & Metabolism
researchProduct

Virus-host interactome: Putting the accent on how it changes

2017

[EN] Viral infections are extremely complex processes that could only be well understood by precisely characterizing the interaction networks between the virus and the host components. In recent years, much effort has gone in this directionwith the aimof unveiling themolecular basis of viral pathology. These networks are mostly formed by viral and host proteins, and are expected to be dynamic bothwith time and space (i.e., with the progression of infection, as well as with the virus and host genotypes; what we call plastodynamic). This largely overlooked spatio-temporal evolution urgently calls for a change both in the conceptual paradigms and experimental techniques used so far to characte…

0301 basic medicineEvolutionSystems biologyBiophysicsComplex diseaseDiseaseComputational biologyBiologyBioinformaticsBiochemistryInteractomeVirusViral Proteins03 medical and health sciencesSpatio-Temporal AnalysisProtein networkVirologyStress (linguistics)AnimalsHumansProtein Interaction MapsVirus host030102 biochemistry & molecular biologyHost (biology)030104 developmental biologyVirus DiseasesHost-Pathogen InteractionsSystems biologyJournal of Proteomics
researchProduct

Rats bred for low aerobic capacity become promptly fatigued and have slow metabolic recovery after stimulated, maximal muscle contractions.

2012

AIM. Muscular fatigue is a complex phenomenon affected by muscle fiber type and several metabolic and ionic changes within myocytes. Mitochondria are the main determinants of muscle oxidative capacity which is also one determinant of muscle fatigability. By measuring the concentrations of intracellular stores of high-energy phosphates it is possible to estimate the energy production efficiency and metabolic recovery of the muscle. Low intrinsic aerobic capacity is known to be associated with reduced mitochondrial function. Whether low intrinsic aerobic capacity also results in slower metabolic recovery of skeletal muscle is not known. Here we studied the influence of intrinsic aerobic capac…

Magnetic Resonance SpectroscopyAnatomy and PhysiologyPhosphocreatineEvolutionary Selectionlcsh:MedicineIsometric exerciseBreedingmetaboliset sairaudetBiochemistrychemistry.chemical_compound0302 clinical medicineTriceps surae muscleMyocyteta315lcsh:ScienceMusculoskeletal System0303 health sciencesMultidisciplinarycomplex diseaseMuscle BiochemistryAnatomyAnimal ModelsHydrogen-Ion Concentrationmedicine.anatomical_structureaerobinen kapasiteettiMuscle FatigueMuscleaerobinen suorituskykymedicine.symptomMuscle contractionMuscle ContractionResearch Articlemedicine.medical_specialtyEvolutionary ProcessessupistusominaisuudetBioenergeticsPhosphocreatinePhosphates03 medical and health sciencesModel OrganismsInternal medicinePhysical Conditioning AnimalmedicineGeneticsAnimalsskeletal muscleAdaptationBiologyAerobic capacity030304 developmental biologyEvolutionary BiologyMuscle fatiguelcsh:RSkeletal muscleElectric StimulationRatsraajalihasEndocrinologyMetabolismcontractile propertieschemistryRatlcsh:QEnergy MetabolismPhysiological ProcessesAnimal Genetics030217 neurology & neurosurgeryPLoS ONE
researchProduct

Mixed cryoglobulinemia type II in chronic hepatitis B associated with HBe-minus HBV mutant: Cellular immune reactions and response to interferon trea…

1994

The case of a young female patient with chronic active hepatitis B, vasculitic purpura, edema, and circulating immune complexes due to mixed Cryoglobulinemia is described. Serum transami-nases were elevated. Serological assays showed hepatitis B surface antigen (HBsAg), antibody to hepatitis B e antigen (anti-HBe), and antibody to hepatitis B core antigen (anti-HBc) antibodies but no antibody to hepatitis C virus (anti-HCV) or antibody to hepatitis delta virus (anti-HDV) antibodies. Using hepatitis B virus-polymerase chain reaction (HBV-PCR) and direct sequencing a precore/core (preC/C) mutant unable to synthesize HBeAg was detected in serum. HBV antigens were demonstrated in the circulatin…

Hepatitis B virusHBsAgAdolescentT-Lymphocytesmedicine.disease_causeAntigenVirologymedicineHumansHepatitis B e AntigensHepatitis ChronicHepatitis B virusImmunity Cellularbiologybusiness.industryInterferon-alphavirus diseasesHepatitis BHepatitis Bmedicine.diseasebiology.organism_classificationVirologydigestive system diseasesHBcAgInfectious DiseasesCryoglobulinemiaHBeAgHepadnaviridaeMutationImmunologyLeukocytes MononuclearFemalebusinessImmune complex diseaseFollow-Up StudiesJournal of Medical Virology
researchProduct

CLEFT PALATE ONLY: CURRENT CONCEPTS

2017

Cleft palate only (CPO) is one of the most common congenital malformations worldwide. The etiopathogenesis of CPO is not completely understood. Environmental factors, such as smoking, alcohol consumption, intake of drugs during pregnancy, advanced paternal age, have been demonstrated to be a risk of CPO, but conflicting results have also been published. Insufficient intake of folic acid during the pregnancy has been suggested to increase the risk for CPO. The demonstrated risk for siblings and the higher risk for monozygotic twins suggest a genetic etiopathogenesis for CPO. In some cases of CPO a prevalent mode of inheritance has been reported, but oligogenic models with reduced penetrance,…

Pediatricsmedicine.medical_specialtyWeaknessComplex diseasePrenatal diagnosisDiseaseCongenital03 medical and health sciences0302 clinical medicinemedicineGenetic epidemiologyOriginal Research Article030223 otorhinolaryngologyAerophagiaGeneral DentistryBirth defects; Cleft palate; Cleft palate only; Congenital; Genetic epidemiology; Dentistry (all)Pregnancybusiness.industrymedicine.diseasePenetranceBirth defectsCleft palate onlyCleft palate030220 oncology & carcinogenesisDentistry (all)Unintelligible speechmedicine.symptombusinessOral & Implantology
researchProduct

Non-coronary atherosclerosis

2014

International audience; During the last decades, the clinical and research interest in atherosclerosis has been mostly focused on coronary arteries. After the publications of the European Society Guidelines and AHA/ACC Guidelines on Peripheral artery diseases, and of the Registry REduction in Atherothrombosis for Continued Health Registry, there has been an increased interest in atherosclerosis of the lower extremity arteries and its presence in multifocal disease. However, awareness in the general population and the medical community of non-coronary artery diseases, and of its major prognostic implications remain relatively low. The aim of this general review stemming out of an ESC Working…

Carotid Artery Diseasesmedicine.medical_specialtyPopulationAortic DiseasesComplex diseaseAorta Thoracic610 Medicine & healthDisease2705 Cardiology and Cardiovascular MedicinePeripheral artery circulationUpper ExtremityRenal ArteryMultifocal diseasemedicineHumansAorta AbdominalPeripheral Artery DiseaseseducationIntensive care medicineCoronary atherosclerosisPeripheral Vascular Diseaseseducation.field_of_studybusiness.industry10031 Clinic for AngiologySettore MED/11 - Malattie Dell'Apparato CardiovascolareMesenteric Arteries3. Good healthCoronary arteriesEarly Diagnosismedicine.anatomical_structureLower ExtremityAtherosclerosiPhysical therapy[SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologieperipheral artery circulation; atherosclerosisArtery diseasesatherosclerosisCardiology and Cardiovascular Medicinebusiness
researchProduct

European Association for the Study of the Liver Hepatocellular Carcinoma summit 2014: old questions, new (or few) answers?

2014

, the European Association for the Study of the Liver (EASL) organized the 2014 EASL HCC Summit in Geneva, Switzerland from 13 to 16 February 2014. A number of interesting issues on the management of hepatocellular carci-noma (HCC) have been addressed during this meeting. However, our feeling is that only few answers have been given to those questions, mainly because of the still poor knowledge of the molecular basis and the natural history of HCC.HCC is a complex disease, associated in the wide majority of cases with under -lying cirrhosis. In addition, HCC pre-sents with high heterogeneity

SorafenibCancer Researchmedicine.medical_specialtygeographyCirrhosisSummitgeography.geographical_feature_categorybusiness.industryCost effectivenessComplex diseaseGeneral Medicinemedicine.diseaseGastroenterologyNatural historyOncologyInternal medicineHepatocellular carcinomaFamily medicineMedicinebusinessmedicine.drugFuture Oncology
researchProduct

Mortality studies for multiple sclerosis: still a useful tool to analyse long-term outcome

2017

Mortality studies represent a useful way to look at the prognosis of a chronic complex disease and to evaluate the impact of therapeutic and caring strategies on long-term outcomes. Results should be interpreted keeping always in mind the following important aspects: first, to what extent the disease affects patient’s life in terms of life expectancy. Second, what is at this moment the real impact that the strategies and measures we adopt to cure and to take care of patients really have on clear and strong endpoints like mortality? In their JNNP manuscript, Lunde et al .1 show a significant reduction in life expectancy in people affected by multiple sclerosis (MS) over a study period of abo…

medicine.medical_specialtyPopulationComplex diseaseDiseaseOutcome (game theory)03 medical and health sciences0302 clinical medicineNEUROEPIDEMIOLOGYmedicine030212 general & internal medicineIntensive care medicineeducationMULTIPLE SCLEROSISeducation.field_of_studybusiness.industryMultiple sclerosismedicine.diseaseSurgeryTerm (time)Psychiatry and Mental healthLife expectancySettore MED/26 - NeurologiaSurgeryNeurology (clinical)business030217 neurology & neurosurgeryJournal of Neurology, Neurosurgery & Psychiatry
researchProduct

Direct and Inverse Comorbidities Between Complex Disorders

2016

Comorbidity and multimorbidity, defined as the presence of more than one disease in individuals, have emerged as a major challenge in the last decade (Valderas et al., 2009). Indeed, researchers, health professionals, healthcare managers and policy makers, and patients and citizens are lagging behind considering the comorbidity scenario, as illustrated by the paucity of documentation concerning interventions in people with multiple conditions (Smith et al., 2012). There is a clear need to better understand disease-disease relationships, in order to better organize and provide care, but also to develop appropriate research models. We can first characterize direct multimorbidity (higher-than-…

0301 basic medicineBiopsychosocial modelNosologymedicine.medical_specialtymedicinemultimorbidityPhysiologymalaltiesContext (language use)Disease03 medical and health sciencesPhysiology (medical)MultimorbidityMedicinecomplex diseasesPsychiatryOMICS dataComputingMilieux_MISCELLANEOUSbusiness.industrymedicine.diseaseComorbidity[SDV.BIBS]Life Sciences [q-bio]/Quantitative Methods [q-bio.QM]3. Good healthcomorbidityEditorial030104 developmental biologyAge of onsetbusinessNeurocognitive
researchProduct